Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Hannah Family

Biographic Data

ID1741499
NAMEHannah Family
GIVEN NAMESHannah
FAMILY NAMEFamily
SIGNATUREFAMILY H
AFFILIATIONSUniversity of Bristol
ORCID0000-0003-1243-778X
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS5
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2026
H-INDEX1
  • Universal Barriers and Facilitators to Systemic Hepatitis C Care

    Open Access•Gabriele Vojt, Lawrie Elliott et al.•ARTICLE•Systems Research and Behavioral…•2026

    Scaling up hepatitis C virus (HCV) testing and treatment for people who inject drugs (PWID) is essential to achieve HCV elimination. We report a retrospective systems‐informed qualitative process evaluation of HCV care across multiple community‐based settings in a region in Scotland, UK. Using secondary data from 71 semi‐structured interviews with HCV service providers ( n = 40) and service users ( n = 31) from across the whole system, we identif…

  • Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP)

    Open Access•Peter Mcculloch, Hannah Family et al.•ARTICLE•International Journal of Drug…•2026

    These findings show how interacting relational and structural mechanisms generate optimal outcomes, guiding policy and service design. Implementing a multi-agency approach, integrating different mechanisms across the identified contexts, may be necessary to achieve optimal service delivery

  • Understanding and learning from rural drug service adaptations to opioid substitution therapy during the Covid-19 pandemic

    Open Access•Jenny Scott, Hannah Family et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction In April 2020, in response to government COVID-19 advice, changes were made to the way English drug services operated. Methadone and buprenorphine were typically dispensed in 1- to 2-week supplies, and key working was conducted by phone/online. Previous studies have examined the impact of these changes on people from urban settings. This study adds the experiences and perspectives of people receiving care from drug services in rural …

  • Contraceptive choice and power amongst women receiving opioid replacement therapy

    Open Access•Joanne Neale, Helena Werthern et al.•ARTICLE•Drugs Education Prevention and…•2022

    nBackground: Women receiving treatment for opioid use disorder have low levels of contraception use and high rates of unintended pregnancies, abortion and children being adopted or fostered. This paper aims to understand the relationship between contraceptive choice and power amongst women receiving Opioid Replacement Therapy (ORT). Methods: During 2016/17, semi-structured interviews were undertaken with 40 women (aged 22–49 years) receiving ORT …

  • Living Under Coronavirus and Injecting Drugs in Bristol (Lucid-B)

    Open Access•Joanna M Kesten, Adam Holland et al.•ARTICLE•International Journal of Drug…•2021

    This study captures the significant impacts and challenges of the COVID-19 pandemic on the lives of PWID. While rapid adaptations to service delivery to help mitigate the risks of COVID-19 were appreciated and some changes such as relaxation of supervised daily OST consumption were viewed positively, barriers to access need further attention. Going forwards there may be opportunities to harness the positive aspects of some changes to services

  • Extending the scope of community pharmacists’ practice to patients requiring urgent care – An evaluation of a training programme using the Theoretical Domains Framework

    Open Access•Sarah Willi, Seston Em et al.•ARTICLE•Health & Social Care in the…•2019•References: 2

    Redesigned health systems could meet the rising demand for healthcare, with community pharmacy currently an underused resource for the treatment and management of patients requiring urgent care. This study aimed to investigate whether a training intervention delivered over 2 days to community pharmacists resulted in behaviour and practice change. Validated measures of psychological motivation and capability factors relevant to understanding behav…

  • A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England

    Open Access•Laura Medina-Perucha, Jenny Scott et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 5•References: 56

  • A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England

    Open Access•Laura Medina-Perucha, Jenny Scott et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 5•References: 56

  • Extending the scope of community pharmacists’ practice to patients requiring urgent care – An evaluation of a training programme using the Theoretical Domains Framework

    Open Access•Sarah Willi, Seston Em et al.•ARTICLE•Health & Social Care in the…•2019•References: 2

    Redesigned health systems could meet the rising demand for healthcare, with community pharmacy currently an underused resource for the treatment and management of patients requiring urgent care. This study aimed to investigate whether a training intervention delivered over 2 days to community pharmacists resulted in behaviour and practice change. Validated measures of psychological motivation and capability factors relevant to understanding behav…

  • A qualitative study on intersectional stigma and sexual health among women on opioid substitution treatment in England

    Open Access•Laura Medina-Perucha, Jenny Scott et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 5•References: 56

  • Living Under Coronavirus and Injecting Drugs in Bristol (Lucid-B)

    Open Access•Joanna M Kesten, Adam Holland et al.•ARTICLE•International Journal of Drug…•2021

    This study captures the significant impacts and challenges of the COVID-19 pandemic on the lives of PWID. While rapid adaptations to service delivery to help mitigate the risks of COVID-19 were appreciated and some changes such as relaxation of supervised daily OST consumption were viewed positively, barriers to access need further attention. Going forwards there may be opportunities to harness the positive aspects of some changes to services

  • Contraceptive choice and power amongst women receiving opioid replacement therapy

    Open Access•Joanne Neale, Helena Werthern et al.•ARTICLE•Drugs Education Prevention and…•2022

    nBackground: Women receiving treatment for opioid use disorder have low levels of contraception use and high rates of unintended pregnancies, abortion and children being adopted or fostered. This paper aims to understand the relationship between contraceptive choice and power amongst women receiving Opioid Replacement Therapy (ORT). Methods: During 2016/17, semi-structured interviews were undertaken with 40 women (aged 22–49 years) receiving ORT …

  • Understanding and learning from rural drug service adaptations to opioid substitution therapy during the Covid-19 pandemic

    Open Access•Jenny Scott, Hannah Family et al.•ARTICLE•Frontiers in Public Health•2023

    Introduction In April 2020, in response to government COVID-19 advice, changes were made to the way English drug services operated. Methadone and buprenorphine were typically dispensed in 1- to 2-week supplies, and key working was conducted by phone/online. Previous studies have examined the impact of these changes on people from urban settings. This study adds the experiences and perspectives of people receiving care from drug services in rural …

  • Universal Barriers and Facilitators to Systemic Hepatitis C Care

    Open Access•Gabriele Vojt, Lawrie Elliott et al.•ARTICLE•Systems Research and Behavioral…•2026

    Scaling up hepatitis C virus (HCV) testing and treatment for people who inject drugs (PWID) is essential to achieve HCV elimination. We report a retrospective systems‐informed qualitative process evaluation of HCV care across multiple community‐based settings in a region in Scotland, UK. Using secondary data from 71 semi‐structured interviews with HCV service providers ( n = 40) and service users ( n = 31) from across the whole system, we identif…

  • Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP)

    Open Access•Peter Mcculloch, Hannah Family et al.•ARTICLE•International Journal of Drug…•2026

    These findings show how interacting relational and structural mechanisms generate optimal outcomes, guiding policy and service design. Implementing a multi-agency approach, integrating different mechanisms across the identified contexts, may be necessary to achieve optimal service delivery

HIV, Drug Use, Sexual Risk (5 works) · Medicine (5 works) · Qualitative research (5 works) · Sociology (4 works) · Family medicine (3 works) · Opioid Use Disorder Treatment (3 works) · Psychology (3 works) · Disease (2 works) · Homelessness and Social Issues (2 works) · Nursing (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae